Archives
AAO: Corneal Toxicity Reported With Mirvetuximab Soravtansine
Corneal toxicity not uncommon with MIRV treatment for primary gynecologic malignancies, usually resolves
AAO: Wastage Seen With Artificial Expiration of Eye Drops in Ophthalmic Clinics
Artificial expiration dates of 14 and 28 days lead to $1,328, 207 g plastic, 11,881 drops wasted per year
IDSA: Antibiotics for Seven Days Feasible for Patients Hospitalized With Bloodstream Infections
Findings show similar 90-day mortality with seven or 14 days of treatment
Geographic Position Influences Climate Change Risk Perception of Emergency Medical Services
Only 21.4 and 37.6 percent of survey respondents reported assessment and preparedness measures, respectively
Study Characterizes Pediatric Patients Self-Presenting With Major Trauma
In a recent study, most patients had obvious external signs of injury
Single-Substance Exposures Causing Seizures Increased in U.S. Children, 2009 to 2023
Diphenhydramine, tramadol, bupropion, and synthetic cannabinoids were linked to increases
IDSA: Vaccination Less Likely With Increasing Social Vulnerability, Black Race
Lower likelihood of vaccination for flu, SARS-CoV-2, RSV seen with increasing quartile of social vulnerability index, especially for Black people
Half of Patients Admitted to an ED for Sepsis Died Within Two Years
Age, cancer, ischemic heart disease, dementia, and previous sepsis admission tied to mortality
IDSA: MVA-BN Vaccine Against Mpox Tolerated, Effective for Teens
Vaccine is well tolerated and peak geometric mean titer met prespecified noninferiority criteria for adolescents
IDSA: EHR Order Set Reduces Antibiotic Duration in Children With AOM
EHR order set that preselected a five-day antibiotic duration increased compliance with recommended antibiotic duration
